L’Oréal Groupe unveiled a revolutionary innovation in skincare technology – the L’Oréal Cell BioPrint. This compact, tabletop device takes only five minutes to deliver a personalised skin analysis, empowering users to understand their skin’s ageing process and make informed skincare choices.
At the heart of this breakthrough is advanced proteomics – the study of proteins and how they influence skin ageing. With this technology, L’Oréal Cell BioPrint offers a deeper understanding of skin’s needs, moving beyond guesswork to science-backed skincare solutions.
How Does It Work?
Using cutting-edge microfluidic lab-on-a-chip technology, developed in collaboration with Korean startup NanoEnTek, the process is simple and non-invasive:
- Place a small facial tape strip on your cheek to collect a sample.
- Put the tape in a buffer solution and load it into the device’s cartridge.
- While the device analyses your sample, a quick questionnaire and facial imaging capture additional details about your skin.
How Does It Help?
In just minutes, the device produces insights into:
- Skin’s Biological Age: Understand how fast your skin is ageing and receive tailored advice to slow the signs of ageing.
- Ingredient Responsiveness: Discover whether active ingredients like retinol will work effectively for your skin.
- Proactive Care: Identify potential future concerns, such as dark spots or enlarged pores, before they become visible, enabling you to take preventive measures.
Redefining Personalised Skincare
Personalisation in skincare is more important than ever. The global skincare market is booming, projected to reach US$ 125 billion in 2024. Yet, a recent survey of 2,000 skincare users in the US revealed that 80% rely on trial and error to find suitable products, with the average person trying seven cleansers before finding the right one.
L’Oréal Cell BioPrint changes this narrative. Powered by decades of research, the device identifies unique protein biomarkers in the skin that signal healthy-looking skin and longevity. These insights help users make proactive skincare decisions based on their skin’s specific needs, reducing the reliance on guesswork.
A Step Towards the Future of Beauty
Barbara Lavernos, Deputy CEO of L’Oréal Groupe, shared her excitement:
“At L’Oréal, we’re always looking toward the future of beauty, blending cutting-edge discoveries with our long-standing beauty expertise. With skin being the largest organ, and a key part of people’s wellbeing, we are thrilled to unveil Cell BioPrint, an exclusive microfluidic lab-on-a-chip technology coupled with our century-long skin science leadership. With the Cell BioPrint device, we offer people the ability to discover deeper insights about their skin through specific biomarkers and to proactively address the beauty and longevity of their skin.”
As the skincare industry evolves, innovations like L’Oréal Cell BioPrint highlight the shift towards science-driven, personalised solutions that truly address individual needs. It’s a glimpse into a future where skincare is smarter, simpler, and more effective for everyone.
With this revolutionary device, L’Oréal is not just keeping up with trends – it’s setting them.
Banner Image Credits: L’Oréal Cell BioPrint
